Literature DB >> 25341572

Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix.

Toyomi Satoh1, Yuji Takei, Isabelle Treilleux, Mojgan Devouassoux-Shisheboran, Jonathan Ledermann, Akila N Viswanathan, Sven Mahner, Diane M Provencher, Linda Mileshkin, Elizabeth Åvall-Lundqvist, Patricia Pautier, Nicholas Simon Reed, Keiichi Fujiwara.   

Abstract

Small cell carcinoma of the cervix (SCCC) is a rare histological entity of uterine cervical cancer. Compared with other common histological types, squamous cell carcinoma or adenocarcinoma, the outcome of SCCC is poor because of the high incidence of nodal or distant metastasis even with early stage. In this review, current consensus of epidemiology, pathology, and initial treatment for SCCC will be discussed.

Entities:  

Mesh：

Year:  2014        PMID： 25341572     DOI： 10.1097/IGC.0000000000000262

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


  29 in total

1.  Patterns of recurrence and survival in neuroendocrine cervical cancer.

Authors:  Shane R Stecklein; Anuja Jhingran; Jennifer Burzawa; Preetha Ramalingam; Ann H Klopp; Patricia J Eifel; Michael Frumovitz
Journal:  Gynecol Oncol       Date:  2016-09-16       Impact factor: 5.482

2.  Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.

Authors:  Deyin Xing; Gang Zheng; John Kenneth Schoolmeester; Zaibo Li; Aparna Pallavajjala; Lisa Haley; Michael G Conner; Russell Vang; Chien-Fu Hung; Tzyy-Choou Wu; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

Review 3.  Small Cell and Other Rare Histologic Types of Cervical Cancer.

Authors:  Zibi Marchocki; Brenna Swift; Allan Covens
Journal:  Curr Oncol Rep       Date:  2022-08-10       Impact factor: 5.945

4.  Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.

Authors:  M Frumovitz; M F Munsell; J K Burzawa; L A Byers; P Ramalingam; J Brown; R L Coleman
Journal:  Gynecol Oncol       Date:  2016-11-04       Impact factor: 5.482

5.  Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract.

Authors:  Michael Frumovitz; Shannon N Westin; Gloria Salvo; Abdulrazzak Zarifa; Mingxuan Xu; Timothy A Yap; Ahnert J Rodon; Daniel D Karp; Abdulrahman Abonofal; Amir A Jazaeri; Aung Naing
Journal:  Gynecol Oncol       Date:  2020-06-11       Impact factor: 5.482

6.  Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer.

Authors:  Michael Frumovitz; Jennifer K Burzawa; Lauren A Byers; Yasmin A Lyons; Preetha Ramalingam; Robert L Coleman; Jubilee Brown
Journal:  Gynecol Oncol       Date:  2016-04-15       Impact factor: 5.482

7.  PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer.

Authors:  Xiaoyu Ji; Lei Sui; Kejuan Song; Teng Lv; Han Zhao; Qin Yao
Journal:  Cancer Med       Date:  2021-06-02       Impact factor: 4.452

8.  Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study.

Authors:  Masahiro Kagabu; Takayuki Nagasawa; Shunsuke Tatsuki; Yasuko Fukagawa; Hidetoshi Tomabechi; Eriko Takatori; Yoshitaka Kaido; Tadahiro Shoji; Tsukasa Baba
Journal:  Medicina (Kaunas)       Date:  2021-05-29       Impact factor: 2.430

9.  Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry.

Authors:  Juan Zhou; Jia-Yuan Sun; Shan-Yu Chen; Feng-Yan Li; Huan-Xin Lin; San-Gang Wu; Zhen-Yu He
Journal:  Onco Targets Ther       Date:  2015-12-23       Impact factor: 4.147

10.  Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients.

Authors:  Jian Chen; Yang Sun; Li Chen; Lele Zang; Cuibo Lin; Yongwei Lu; Liang Lin; An Lin; Hu Dan; Yiyu Chen; Haixin He
Journal:  PeerJ       Date:  2021-07-06       Impact factor: 2.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.